Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
These services are provided by third parties
The injectable weight loss medication contains tirzepatide, a GLP-1/GIP agonist, to treat obesity or weight-related health problems
Clinical evidence shows injectable GLP-1 medications produce weight loss of 15-22% body weight reduction over 68 weeks in most patients
Monitoring heart rate and symptoms like palpitations or dizziness is essential during treatment
The page leans into safety and side-effect planning and the details behind BPC-157, dosing, safety and pharmacy quality
US$ 20.13
US$ 23.92
US$ 20.63
